Patients with gout living in rural vs urban areas face a significantly higher risk for MI-related hospitalization.

Adult-onset type 1 diabetes is associated with an increased risk for death and major adverse cardiovascular events.

The increased rate of venous thromboembolism among patients with chronic kidney disease (CKD) warrants increased clinical attention.

Glucagon-like peptide-1 receptor agonists may cut the risk of obesity-related cancer in patients being treated for diabetes and obesity.

For patients with immune-mediated inflammatory diseases, CVD mortality decreased from 1999 to 2020, but sex disparities ...

A scientific statement has been published by the AHA regarding palliative care and advanced cardiovascular disease in adults.

The FDA has approved Optison for use in pediatric patients with suboptimal echocardiograms to opacify the left ventricle and to improve the delineation of the left ventricle endocardial borders.

Hormone reset diets have taken off on social media as the latest weight loss trend, but their scientific validity remains questionable.

A US study found a significantly higher cost of care associated with cirrhosis vs with heart failure or chronic obstructive pulmonary disease.

Following HDP, Black and Hispanic patients, compared with White patients, are less likely to attend a postpartum visit.

Following discharge for COVID-19 hospitalization, county-level social deprivation does not affect long-term cardiovascular risk.

Topline data were announced from a phase 3 trial evaluating olezarsen in patients with moderate hypertriglyceridemia with or at risk for ASCVD.